Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. (JAMA, 2012)

(untitled) - Gossger, N; Snape, MD; Yu, L; Finn, A; Bona, G; Esposito, S; Principi, N; Diez-Domingo, J; Sokal, E; Becker, B; Kieninger, D; Prymula, R; et al.